« Contrarian Endowment Management Helps Manhattan's Cooper Union Thrive In Recession | Main | 25 Memorable Buffett Quotes »

Andy Kern's Thesis on CombiMatrix (CBMX)

Andy Kern of Empirical Finance LLC makes an interesting case for microcap biotech company CombiMatrix (CBMX). While biotech is not typically fertile hunting ground for value-oriented investors, CombiMatrix may be different.

Disclosure: No position.

Posted by manualofideas on September 3, 2009 03:56 PM |

Post a comment

(If you haven't left a comment here before, you may need to be approved by the site owner before your comment will appear. Until then, it won't appear on the entry. Thanks for waiting.)